期刊
CHEMICAL ENGINEERING SCIENCE
卷 230, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.ces.2020.116181
关键词
Protein crystallization; Continuous crystallization; Lysozyme; Pharmaceuticals; Crystal growth
资金
- Nanyang Technological University
The development of a segmented slug flow crystallizer (SFC) design improved the reproducibility of crystal size distribution by limiting the formation of small crystals and large agglomerates, resulting in the production of lysozyme crystals with well-preserved bioactivity.
Continuous crystallization of proteins at short residence time and high supersaturation level is attractive in terms of the space-time yield and production efficiency. Nevertheless, it is rarely pursued due to its less-than-desirable crystal size distribution (CSD) characterized by the abundance of small crystals due to high nucleation rate. The small crystals were prone to random agglomeration, resulting in poor crystals' residence time distribution, hence low CSD's reproducibility. Herein we developed a segmented slug flow crystallizer (SFC) design operated at short residence time (<30 min) comprising a short nucleation segment and a growth segment operated at different temperature and fluid velocity. The SFC design improved the CSD's reproducibility by limiting small crystals and large-sized agglomerates formations as evidenced by the small coefficient-of-variations between replicates (<10%). Lysozyme crystals having size of roughly 13-14 mm with well-preserved bioactivity were produced at yield and space-time yield of approximately 67% (w/w) and 93 g/L.h, respectively. (C) 2020 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据